Markers that have been associated with informative aberrant antigen expression profiles for MRD monitoring in MM include: CD19, CD56, CD45, CD38, CD27, and to a less extent also CD20, CD28, CD33, CD117, and SmIg. Here, PTPRC is linked to Miyoshi myopathy.